Suneel Gupta
44Patents
13h-index
35Co-inventors
81Inventor score
Filing activity: Jun 7, 1995 → Jan 15, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6919373B1 | Methods and devices for providing prolonged drug therapy | Human Necessities | 264 | Expired |
| US6930129B2 | Methods and devices for providing prolonged drug therapy | Human Necessities | 118 | Expired |
| US5983130A | Electrotransport agent delivery method and apparatus | Human Necessities | 100 | Expired |
| US8163798B2 | Methods and devices for providing prolonged drug therapy | Human Necessities | 66 | Active |
| US9393192B2 | Methods and dosage forms for controlled delivery of paliperidone and risperidone | Human Necessities | 50 | Active |
| US6512010B1 | Formulations for the administration of fluoxetine | Human Necessities | 33 | Expired |
| US10688058B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 23 | Active |
| US10098845B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 23 | Active |
| US10292935B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 22 | Active |
| US10987313B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 21 | Active |
| US7011844B2 | Formulations for the administration of fluoxetine | Human Necessities | 21 | Expired |
| US10973769B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 20 | Active |
| US11357733B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US6136327A | Stereospecific delivery of a drug using electrotransport | Human Necessities | 12 | Expired |
| US11666538B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 11 | Active |
| US11622941B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 11 | Active |
| US6219576A | Programmed adjustment of electric current to provide desired electrically assisted transdermal drug delivery rate | Human Necessities | 8 | Expired |
| US6718201B1 | Electrotransport agent delivery method and apparatus | Human Necessities | 6 | Expired |
| US8629179B2 | Methods and devices for providing prolonged drug therapy | Human Necessities | 5 | Active |
| US9000038B2 | Methods and devices for providing prolonged drug therapy | Human Necessities | 5 | Active |
| US9029416B2 | Methods and devices for providing prolonged drug therapy | Human Necessities | 5 | Expired |
| US9144549B2 | Methods and devices for providing prolonged drug therapy | Human Necessities | 5 | Active |
| US12178919B2 | Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US7572252B1 | Electrotransport agent delivery method and apparatus | Human Necessities | 1 | Expired |
| US12064521B2 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.